Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 98, Issue 1, 2010, Pages 25-34

  Ferenc, Peter ^a   Solár, Peter ^a   Kleban, Ján ^a   Mikeš, Jaromír ^a   Fedoročko, Peter ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Akt; Bcl 2; Breast cancer; Genistein; Hypericin; Photodynamic therapy

Indexed keywords

CASPASE 7; GENISTEIN; HYPERICIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; UPREGULATION;

BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CASPASE 7; CELL DIVISION; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; G2 PHASE; GENISTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PERYLENE; PHOSPHORYLATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 73249129188     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.10.004     Document Type: Article

References (60)

1. Allison R., Mang T., Hewson G., Snider W., and Dougherty D. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91 (2001) 1-8
2. Lavie G., Mazur Y., Lavie D., and Meruelo D. The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med. Res. Rev. 15 (1995) 111-119
3. Wilson B.C. Photodynamic therapy for cancer: principles. Can. J. Gastroenterol. 16 (2002) 393-396
4. Mirossay A., Mojzis J., Tothova J., Hajikova M., Lackova A., and Mirossay L. Hypocrellin and hypericin-induced phototoxicity of HL-60 cells: apoptosis or necrosis?. Phytomedicine 7 (2000) 471-476
5. Solar P., Cavarga I., Hofmanova J., Cekanova-Figurova M., Miskovsky P., Brezani P., Hrckova G., Kozubik A., and Fedorocko P. Effect of acetazolamide on hypericin photocytotoxicity. Planta Med. 68 (2002) 658-660
6. Du H.Y., Bay B.H., and Olivo M. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Int. J. Oncol. 22 (2003) 1019-1024
7. Agostinis P., Vandenbogaerde A., Donella-Deana A., Pinna L.A., Lee K.T., Goris J., Merlevede W., Vandenheede J.R., and De Witte P. Photosensitized inhibition of growth factor-regulated protein kinases by hypericin. Biochem. Pharmacol. 49 (1995) 1615-1622
8. Frew T., Powis G., Berggren M., Abraham R.T., Ashendel C.L., Zalkow L.H., Hudson C., Qazia S., Gruszecka-Kowalik E., Merriman R., et al. A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors. Anticancer Res. 14 (1994) 2425-2428
9. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., and Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
10. Constantinou A.I., Kamath N., and Murley J.S. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer 34 (1998) 1927-1934
11. Martin P.M., Horwitz K.B., Ryan D.S., and McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103 (1978) 1860-1867
12. Yu Z., Li W., and Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 215 (2004) 159-166
13. Zava D.T., and Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27 (1997) 31-40
14. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., and Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer 30A (1994) 1675-1682
15. Watanabe T., Shiraishi T., Sasaki H., and Oishi M. Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner. Exp. Cell Res. 183 (1989) 335-342
16. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., Helferich W.G., and Katzenellenbogen J.A. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 12 (2004) 1559-1567
17. Liu S., Sugimoto Y., Kulp S.K., Jiang J., Chang H.L., Park K.Y., Kashida Y., and Lin Y.C. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha. Anticancer Res. 22 (2002) 3917-3923
18. Jang E.R., Lim S.J., Lee E.S., Jeong G., Kim T.Y., Bang Y.J., and Lee J.S. The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene 23 (2004) 1724-1736
19. Rajah T.T., Du N., Drews N., and Cohn R. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Pharmacology 84 (2009) 68-73
20. Li Z., Li J., Mo B., Hu C., Liu H., Qi H., Wang X., and Xu J. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 22 (2008) 1749-1753
21. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
22. Kumar R., Vadlamudi R.K., and Adam L. Apoptosis in mammary gland and cancer. Endocr. Relat. Cancer 7 (2000) 257-269
23. Yin X.M., Oltvai Z.N., and Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369 (1994) 321-323
24. Tai Y.T., Strobel T., Kufe D., and Cannistra S.A. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res. 59 (1999) 2121-2126
25. Marchal S., Francois A., Dumas D., Guillemin F., and Bezdetnaya L. Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells. Br. J. Cancer 96 (2007) 944-951
26. Miller J.D., Baron E.D., Scull H., Hsia A., Berlin J.C., McCormick T., Colussi V., Kenney M.E., Cooper K.D., and Oleinick N.L. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 224 (2007) 290-299
27. Vantieghem A., Xu Y., Assefa Z., Piette J., Vandenheede J.R., Merlevede W., De Witte P.A., and Agostinis P. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J. Biol. Chem. 277 (2002) 37718-37731
28. Kessel D. Promotion of PDT efficacy by a Bcl-2 antagonist. Photochem. Photobiol. 84 (2008) 809-814
29. Bharti A.C., and Aggarwal B.B. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64 (2002) 883-888
30. Granville D.J., Carthy C.M., Jiang H., Levy J.G., McManus B.M., Matroule J.Y., Piette J., and Hunt D.W. Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood 95 (2000) 256-262
31. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
32. Gong L., Li Y., Nedeljkovic-Kurepa A., and Sarkar F.H. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22 (2003) 4702-4709
33. Janicke R.U., Sprengart M.L., Wati M.R., and Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273 (1998) 9357-9360
34. Vojtesek B., Bartek J., Midgley C.A., and Lane D.P. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods 151 (1992) 237-244
35. Uzdensky A.B. Signal transduction and photodynamic therapy. Curr. Signal Transduct. Ther. 3 (2008) 55-74
36. Vandenbogaerde A.L., Cuveele J.F., Proot P., Himpens B.E., Merlevede W.J., and de Witte P.A. Differential cytotoxic effects induced after photosensitization by hypericin. J. Photochem. Photobiol. B 38 (1997) 136-142
37. Solar P., Koval J., Mikes J., Kleban J., Solarova Z., Lazur J., Hodorova I., Fedorocko P., and Sytkowski A.J. Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. Mol. Cancer Ther. 7 (2008) 2263-2271
38. Xue L.Y., Chiu S.M., and Oleinick N.L. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp. Cell Res. 263 (2001) 145-155
39. Hara T., Omura-Minamisawa M., Chao C., Nakagami Y., Ito M., and Inoue T. Bcl-2 inhibitors potentiate the cytotoxic effects of radiation in Bcl-2 overexpressing radioresistant tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 517-528
40. Tzung S.P., Kim K.M., Basanez G., Giedt C.D., Simon J., Zimmerberg J., Zhang K.Y., and Hockenbery D.M. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat. Cell Biol. 3 (2001) 183-191
41. Morris R.L., Azizuddin K., Lam M., Berlin J., Nieminen A.L., Kenney M.E., Samia A.C., Burda C., and Oleinick N.L. Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy. Cancer Res. 63 (2003) 5194-5197
42. Roland C.L., Harken A.H., Sarr M.G., and Barnett Jr. C.C. ICAM-1 expression determines malignant potential of cancer. Surgery 141 (2007) 705-707
43. Usuda J., Azizuddin K., Chiu S.M., and Oleinick N.L. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem. Photobiol. 78 (2003) 1-8
44. Hu Y., Dragowska W.H., Wallis A., Duronio V., and Mayer L. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer. Breast Cancer Res. Treat. 70 (2001) 11-20
45. Ismail I.A., Kang K.S., Lee H.A., Kim J.W., and Sohn Y.K. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur. J. Pharmacol. 575 (2007) 12-20
46. Akimoto T., Nonaka T., Ishikawa H., Sakurai H., Saitoh J.I., Takahashi T., and Mitsuhashi N. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 195-201
47. Tophkhane C., Yang S., Bales W., Archer L., Osunkoya A., Thor A.D., and Yang X. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms. Int. J. Oncol. 31 (2007) 867-874
48. Mikes J., Kleban J., Sackova V., Horvath V., Jamborova E., Vaculova A., Kozubik A., Hofmanova J., and Fedorocko P. Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin. Photochem. Photobiol. Sci. 6 (2007) 758-766
49. Das A., Banik N.L., and Ray S.K. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int. J. Cancer 119 (2006) 2575-2585
50. Vladusic E.A., Hornby A.E., Guerra-Vladusic F.K., Lakins J., and Lupu R. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol. Rep. 7 (2000) 157-167
51. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., and Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 (1994) 1799-1805
52. Sackova V., Fedorocko P., Szilardiova B., Mikes J., and Kleban J. Hypericin-induced photocytotoxicity is connected with G2/M arrest in HT-29 and S-phase arrest in U937 cells. Photochem. Photobiol. 82 (2006) 1285-1291
53. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., and Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
54. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
55. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 3 (2000) 561-576
56. Chinni S.R., Alhasan S.A., Multani A.S., Pathak S., and Sarkar F.H. Pleotropic effects of genistein on MCF-7 breast cancer cells. Int. J. Mol. Med. 12 (2003) 29-34
57. Matsubara A., Nakazawa T., Noda K., She H., Connolly E., Young T.A., Ogura Y., Gragoudas E.S., and Miller J.W. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4741-4747
58. Bozkulak O., Wong S., Luna M., Ferrario A., Rucker N., Gulsoy M., and Gomer C.J. Multiple components of photodynamic therapy can phosphorylate Akt. Photochem. Photobiol. 83 (2007) 1029-1033
59. Schieke S.M., von Montfort C., Buchczyk D.P., Timmer A., Grether-Beck S., Krutmann J., Holbrook N.J., and Klotz L.O. Singlet oxygen-induced attenuation of growth factor signaling: possible role of ceramides. Free Radical Res. 38 (2004) 729-737
60. Zhuang S., and Kochevar I.E. Singlet oxygen-induced activation of Akt/protein kinase B is independent of growth factor receptors. Photochem. Photobiol. 78 (2003) 361-371